Day: January 13, 2021

The CF Foundation’s partial funding of the U.S. trial has been extended to partial funding of the global clinical trial program which includes Europe and IsraelExpect to report top line data from our Phase 2 cystic fibrosis clinical trial program for ELX-02 in the first half of 2021Eloxx had previously reported the formation of a joint program advisory group with the CF Foundation focused on the development of ELX-02 in cystic fibrosisWALTHAM, Mass., Jan. 13, 2021 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by nonsense mutations limiting production of functional proteins, today announced an expansion of its agreement with the CF Foundation beyond the U.S....

Roflumilast cream potential “Best in Class” topical PDE4 inhibitorAtopic dermatitis affects approximately 19 million patients in the U.S.The Company anticipates topline data in the second half of 2022WESTLAKE VILLAGE, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a medical dermatology company developing innovative treatments for patients with immune-mediated dermatological diseases and conditions, today announced that it has commenced pivotal Phase 3 clinical trials evaluating topical roflumilast cream (ARQ-151) as a potential treatment for atopic dermatitis (AD). Roflumilast cream is a once daily topical formulation of roflumilast, a highly potent and selective phosphodiesterase type 4 inhibitor (PDE4), which the Company is developing for plaque psoriasis and AD.“More than 19 million people...

TORONTO, Jan. 13, 2021 (GLOBE NEWSWIRE) — Discovery Metals Corp. (TSX-V: DSV, OTCQX: DSVMF) (“Discovery” or the “Company”) announces that it has granted to certain officers, directors, employees and/or consultants of the Company an aggregate of 5,500,000 options to acquire common shares of the Company (“Options”). The Options have an exercise price of $1.89 per share, have a five-year term from the date of grant (expiration date of January 12, 2026), and vest according to the following schedules: 1) Management and employees: annually in equal thirds beginning on the date of grant; 2) Directors: annually in equal halves beginning on the date of grant; and 3) Consultants: quarterly in equal eighths beginning three months after the date of grant. Any common shares issuable upon exercises of Options will, in accordance with applicable...

CHICAGO, Jan. 13, 2021 (GLOBE NEWSWIRE) — Sprout Social, an industry-leading provider of cloud-based social media management software, has been named one of the best places to work in 2021 by Glassdoor’s Employees’ Choice Award in the US small and medium company category. This is the fourth year Sprout has received this recognition which is based solely on the input of employees who complete an anonymous review about their job, work environment and employer on Glassdoor.“The past year brought significant challenges to our world, but the Sprout team proved to be nothing short of remarkable,” said Justyn Howard, Sprout Social’s CEO and co-founder. “In the face of COVID-19, racial injustice and countless other challenges, we’re incredibly proud of the way our entire team came together to support one another and solve hard problems...

SUNNYVALE, CALIF., Jan. 13, 2021 (GLOBE NEWSWIRE) — Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2020 financial results ahead of its participation at the 39th Annual JP Morgan Healthcare Conference on January 11-14, 2021.Financial and Operational HighlightsFourth quarter 2020 worldwide da Vinci procedures increased approximately 6% compared with the fourth quarter of 2019, reflecting continued disruption caused by the COVID-19 pandemic. Full year 2020 worldwide da Vinci procedures increased approximately 1% compared with 2019.The Company shipped 326 da Vinci Surgical Systems in the fourth quarter of 2020, compared with 336 in the fourth quarter of 2019. The Company...

SUNNY ISLES, Fla., Jan. 13, 2021 (GLOBE NEWSWIRE) — Bespoke Extracts, Inc. (OTC Pink: BSPK), producer of high quality, hemp-derived CBD products, today announced its plan to reintroduce UMF® (Unique Mānuka Factor) 15+ rated Mānuka Honey-infused CBD formulations to be available for purchase on www.bespokeextracts.com beginning in February 2021.   Raw Mānuka Honey used in Bespoke’s new products is imported directly from the north island of New Zealand from a supplier which has been supplying quality bee products since 1974. Mānuka Honey is one of the most unique and beneficial forms of honey in the world, and carries the industry’s UMF® 15+ rating, distinguishing it as superior high-grade Mānuka. A higher UMF grade indicates greater concentration of the Mānuka Honey’s nutritional attributes and the purer the honey is. To be considered...

OTTAWA, Jan. 13, 2021 (GLOBE NEWSWIRE) — Truss CBD USA, a joint venture between HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) and Molson Coors Beverage Company (“Molson Coors”) (NYSE: TAP), today announced the U.S. launch of VeryvellTM, a new line of non-alcoholic, sparkling CBD beverages, exclusively available in Colorado.VeryvellTM is a hemp-derived, adaptogenic, sparkling CBD water now available to Colorado-based consumers in three flavours: Focus (Grapefruit Tarragon), Mind & Body (Strawberry Hibiscus) and Unwind (Blueberry Lavender). VeryvellTM is Powered by HEXOTM, the recognized quality and innovation behind award-winning products.“We are excited to launch VeryvellTM in Colorado through Truss CBD USA, in collaboration with our partner, Molson Coors. Our joint venture with Molson Coors Canada saw Truss...

OTTAWA, 13 janv. 2021 (GLOBE NEWSWIRE) — Truss CBD USA, une coentreprise entre HEXO Corp (« HEXO » ou la « Société ») (TSX: HEXO; NYSE: HEXO) et Molson Coors entreprise de boissons (« Molson Coors ») (NYSE: TAP), ont annoncé aujourd’hui le lancement aux États-Unis de VeryvellTM, une nouvelle gamme de boissons pétillantes non alcoolisées au CBD qui ne sera distribuée qu’au Colorado.VeryvellTM est une eau pétillante au CBD. Adaptogène et dérivée du chanvre, elle est désormais offerte aux consommateurs du Colorado en trois saveurs : Focus (pamplemousse et estragon), Mind & Body (fraise et hibiscus) et Unwind (bleuet et lavande). VeryvellTM fait partie de la gamme de produits primés Powered by HEXOTM, dont la qualité et l’innovation sont reconnues.« Nous sommes ravis de lancer VeryvellTM dans le Colorado par l’entremise de Truss...

BEVERLY HILLS, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — RideShare Rental, Inc., formerly YayYo, Inc (“RSR” or the “Company”) (Other OTC:YAYO), which, acting through its wholly-owned subsidiary, Rideshare Car Rentals, LLC, is a leading provider of vehicles to the rideshare and delivery gig economy industry, today announced that its Chief Executive Officer, Ramy El-Batrawi, has increased his ownership position in YAYO common stock by five million (5,000,000) shares. Mr. El-Batrawi received these shares through an exchange transaction (valued at $3 a share for a total of $15,000,000) with RSR’s largest stockholder, the Gray Mars Venus Trust, Arizona 2015 (the “Trust”). The shares will be held as an asset of X, LLC, a Delaware limited liability company, of which Mr. El-Batrawi is managing member and Mr. El-Batrawi will have sole voting...

West Palm Beach, FL, Jan. 13, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Ethema Health Corporation (OTCPINK: GRST) (“Ethema” “GRST” or the “Company”) is pleased to announce that the audit for the full licensing of the ARIA treatment facility by the Department of Children and Family Service for Florida (“DCF”) which commenced on December 10, 2020 has resulted in the issuance of a full license for all five levels of care that ARIA provides. The issuance of the full licenses for each level of care were staggered and the full licenses for the final two levels of care were received January 12, 2021.  The Company previously announced that it had expected the process to take several days and instead took just over a month.  The licensing process has become far more arduous in recent months due to many new requirements by DCF and...